U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. King of Pops - Close Out Letter 1/12/18
  1. Warning Letters

CLOSEOUT LETTER

King of Pops


Recipient:
King of Pops


United States

Issuing Office:

United States


 

  

Black HHS-Blue FDA Logo

 

Atlanta District Office
60 Eighth Street N.E.
Atlanta, GA 30309 

 
 

January 12, 2018

Nicholas Carse, COO
Steven Carse, CEO
King of Pops, LLC
337 Elizabeth Street, NE, Suite B
Atlanta, GA 30307

The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter [17-ATL-10 dated August 3, 2017]. Based on our evaluation during the December 4, 2017 visit to your facility, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

If you have any questions regarding this letter, you may contact Janice L. King, Compliance Officer, U.S. Food and Drug Administration, 4600 Goer Drive, #106, North Charleston, SC 29406. You may also contact Compliance Officer King at (843) 746-2990 x16 or via email at janice.king@fda.hhs.gov.

Sincerely,
/S/

Derek Price
Compliance Branch Director
U.S. Food & Drug Adminisration
FDA Atlanta District
Office of Human and Animal Foods- Division 3 East
(Georgia- North Carolina-South Carolina)
Office of Regulatory Affairs